Integral Diagnostics Limited

ASX:IDX Voorraadrapport

Marktkapitalisatie: AU$699.4m

Integral Diagnostics Beheer

Beheer criteriumcontroles 2/4

De CEO Integral Diagnostics is Ian Kadish, benoemd in May2017, heeft een ambtstermijn van 7.5 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 1.24M, bestaande uit 66.3% salaris en 33.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.25% van de aandelen van het bedrijf, ter waarde A$ 1.73M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3 jaar en 1.8 jaar.

Belangrijke informatie

Ian Kadish

Algemeen directeur

AU$1.2m

Totale compensatie

Percentage CEO-salaris66.3%
Dienstverband CEO7.5yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn5yrs
Gemiddelde ambtstermijn bestuur2.3yrs

Recente managementupdates

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20
Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14
These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26
Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28
Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25
Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29
Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13
Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04
An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14
Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03
Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16
We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17
Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Mar 07
The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Feb 25
Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Feb 23
Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Feb 13
Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03
Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14
Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05
Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17
At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08
What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29
Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19
Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Sep 20
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Analyse CEO-vergoeding

Hoe is Ian Kadish's beloning veranderd ten opzichte van Integral Diagnostics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024AU$1mAU$825k

-AU$61m

Mar 31 2024n/an/a

-AU$59m

Dec 31 2023n/an/a

-AU$58m

Sep 30 2023n/an/a

-AU$16m

Jun 30 2023AU$1mAU$794k

AU$25m

Mar 31 2023n/an/a

AU$23m

Dec 31 2022n/an/a

AU$21m

Sep 30 2022n/an/a

AU$18m

Jun 30 2022n/aAU$781k

AU$15m

Mar 31 2022n/an/a

AU$18m

Dec 31 2021n/an/a

AU$22m

Sep 30 2021n/an/a

AU$26m

Jun 30 2021AU$2mAU$736k

AU$31m

Mar 31 2021n/an/a

AU$32m

Dec 31 2020n/an/a

AU$32m

Sep 30 2020n/an/a

AU$28m

Jun 30 2020AU$1mAU$635k

AU$23m

Mar 31 2020n/an/a

AU$22m

Dec 31 2019n/an/a

AU$21m

Sep 30 2019n/an/a

AU$21m

Jun 30 2019AU$876kAU$549k

AU$21m

Mar 31 2019n/an/a

AU$19m

Dec 31 2018n/an/a

AU$17m

Sep 30 2018n/an/a

AU$16m

Jun 30 2018AU$711kAU$489k

AU$15m

Compensatie versus markt: De totale vergoeding ($USD 823.84K ) Ian } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 923.16K ).

Compensatie versus inkomsten: De vergoeding van Ian is gestegen terwijl het bedrijf verliesgevend is.


CEO

Ian Kadish (61 yo)

7.5yrs

Tenure

AU$1,243,752

Compensatie

Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ian Kadish
CEO, MD & Director7.5yrsAU$1.24m0.25%
A$ 1.8m
Jacqueline Milne
Executive Director5yrsAU$1.15m0.011%
A$ 75.3k
Scott Paterson
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Julian Gully
Chief Information Officer5.2yrsgeen gegevensgeen gegevens
John Merity
Company Secretaryless than a yeargeen gegevensgeen gegevens

5.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van IDX wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Ian Kadish
CEO, MD & Directorno dataAU$1.24m0.25%
A$ 1.8m
Jacqueline Milne
Executive Director5yrsAU$1.15m0.011%
A$ 75.3k
Raelene Murphy
Independent Non-Executive Director7.1yrsAU$140.53k0.013%
A$ 92.5k
Andrew Fay
Independent Non-Executive Director2.3yrsAU$137.50k0.036%
A$ 254.2k
Ingrid Player
Independent Non-Executive Director1.3yrsAU$111.22k0.015%
A$ 104.6k
James Hall
Independent Non-Executive Chairman1.2yrsAU$168.37k0.065%
A$ 453.6k

2.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IDX wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw bestuur.